Novel Vital-sign Patient-assisted Intravenous Analgesia With Remifentanil for Labour Pain to Reduce Maternal Desaturation and Improve Analgesic Titration: a Prospective Cohort Study
Phase of Trial: Phase IV
Latest Information Update: 10 Feb 2017
At a glance
- Drugs Remifentanil (Primary)
- Indications Labour pain
- Focus Adverse reactions
- 05 Feb 2017 Planned End Date changed from 1 Dec 2017 to 1 Mar 2018.
- 05 Feb 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Dec 2017.
- 05 Feb 2017 Status changed from not yet recruiting to recruiting.